Back to Startups

CureGene Pharma

About CureGene Pharma

CureGene focuses on therapeutic areas including cardiovascular and metabolic diseases, developing innovative therapies to improve patient outcomes.

Business Information
Target Customers
healthcare providers hospitals pharmacies research institutions
Industry Categories
Bioscience & Disease Healthcare Systems
Business Model
Revenue Model Pharmaceutical sales
Pricing Strategy Value-based pricing
Sales Channels direct sales, distributors, partnerships with healthcare organizations
Funding Timeline
Round Date Amount Investors
Series B May 20, 2025 $14.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
chuminhua432
Minhua Chu @chuminhua432
May 20, 2025

🇨🇳 Shanghai #CureGene Pharma announced the completion of its Series B+ financing, raising over 100 million RMB in total. This round follows the initial investment in Sept 2024. Founded in 2018, CureGene focuses on therapeutic areas including cardiovascular/metabolic diseases and